lol. here is what should actually concern people, that this sh*t treatment is still most likely 4 years away optimistically speaking. they want to start enrollment for their phase 3 trial in Q4 2019, enrollment for phase 3 winlevi started in Q4 2016 which means breezula is pretty much exactly 3 years behind winlevi. winlevi will not come out before the end of 2020, probably Q4. so we are looking at a potential release of CB for Q4 2023 if everything goes well. thats still 4.5 years away, absolutely insane if you ask me. im basically trying to forget about this treatment altogether, it's just a sick joke that people have to wait to the midth of the 2020 for a topical androgen, thats absolutely embarrassing.
this company is running out of money, it's dying and I would not even be surprised if this sh*t never reaches market and gets stuck in patent limbo for the rest of the first half of century.
they are smart though, I followed them, they had 2019 release initially and 2021 for breezula. then they changed it to Q42019/Q12020, then to H1 2020 and now it says just 2020 lol.
people don't realize this but even 2022 which is already morbidly depressing is unrealistic for CB to reach the market. it will take winlevi 4 years to go from enrollment of phase 3 to market release, I really don't see the point anymore in any of this.
maybe you are right, maybe I am naive but hair loss research is the single most pathetic thing I have seen in my life
I am quite confident there will be further delays especially if you read their announcements in order, every year half a year is added to the timeline.
then again, I am from sh*t hole europe and this treatment won't even be on this market before what, 2025? why not make it 2030? why not wait until 2040 to bring out a topical androgen, that'd be fun. you literally can't make this sh*t up, the best thing to look forward to now is a topical anti androgen that is in the most realistic case 5 years away to be available on the european market. anybody who doesn't get clinically depressive with this in mind has lost theirs.